GlassScriptPhysician profile
Augusta Slocum
NPI 1427428077
$1,804.33
in general payments reported to CMS, 2019-2025
28 companies · $624 in 2025
The $624 reported for 2025 was more than what 77% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $26.05 · 2023: $556 · 2024: $598 · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,678 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,678.29 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $393.47 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $184.30 | 2023 | |
| Merck Sharp & Dohme LLC | $160.34 | 2023-2025 | Keytruda, Dificid, Welireg |
| Novo Nordisk INC | $116.71 | 2023-2024 | Wegovy |
| Seagen INC. | $99.99 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $90.97 | 2025 | Onivyde |
| Astrazeneca Pharmaceuticals LP | $84.15 | 2023-2024 | Breztri, Flumist Quadrivalent, Airsupra |
| Pfizer INC. | $78.45 | 2023-2025 | |
| Lilly USA, LLC | $58.60 | 2023-2024 | Mounjaro, Zepbound |
| Janssen Biotech, INC. | $55.62 | 2024-2025 | Rybrevant, Talvey, Darzalex |
| Tempus Ai, INC | $50.97 | 2025 | Xt Cdx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.24 | 2023-2024 | Jardiance |
| Exact Sciences Corporation | $41.98 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Genzyme Corporation | $36.14 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $36.06 | 2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $33.58 | 2023 | Rexulti |
| Shield Therapeutics INC | $32.40 | 2024 | |
| Glaxosmithkline, LLC. | $31.04 | 2023-2025 | Jemperli, Trelegy Ellipta |
| Caris Mpi, INC. | $21.61 | 2025 | Mi Cancer Seek |
| Janssen Pharmaceuticals, INC | $20.26 | 2024 | Spravato |
| Seqirus USA INC | $19.39 | 2024 | Flucelvax, Fluad |
| Cumberland Pharmaceuticals, INC. | $18.20 | 2025 | Sancuso |
| Novocure INC. | $17.58 | 2025 | Optune Lua (Novottf-200t) |
| Medtronic, INC. | $16.67 | 2024 | Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.70 | 2023 | Xifaxan |
| Agios Pharmaceuticals, INC. | $14.66 | 2024 | |
| Puma Biotechnology, INC. | $13.77 | 2024 | |
| Genentech USA, INC. | $13.48 | 2024 | Polivy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Augusta Slocum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.